Compounds > anidulafungin
Page last updated: 2024-09-05

anidulafungin and HIV Infections

anidulafungin has been researched along with HIV Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP1
Chang, HC; Chen, TC; Yang, WT1

Other Studies

2 other study(ies) available for anidulafungin and HIV Infections

ArticleYear
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole

2018
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:24

    Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Antiretroviral Therapy, Highly Active; Glucosephosphate Dehydrogenase Deficiency; HIV Infections; Humans; Immunocompromised Host; Male; Pneumonia, Pneumocystis; Treatment Outcome; Young Adult

2018